Becton Dickinson and Co
Score: Negative (13)
15 days at current score.
Downgraded from Neutral on November 29th 2018
- This company ranked positively in 3 out of 4 IHS Markit Categories but negatively compared to the Healthcare sector
- Perception of the company's creditworthiness is negative
- ETFs holding this stock are seeing positive inflows
- Bearish sentiment is low
- Economic output in this company's sector is expanding
Short interest | Positive
Short interest is low for BDX with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
ETF/Index ownership | Positive
ETF activity is positive. Over the last month, growth of ETFs holding BDX is favorable, with net inflows of $14.53 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
PMI by IHS Markit | Positive
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year.
Credit default swap | Negative
The current level displays a negative indicator. BDX credit default swap spreads are at their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.
Please send all inquiries related to the report to firstname.lastname@example.org .
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report .